Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine + nifedipine for tenesmus in distal ulcerative colitis
2006-003340-33Phase 2Completed
- Sponsor
- Bracco Group
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Salcrozine and nifedipine in autoimmune colitis, ulcerative proctitis and Ulcerative rectosigmoiditis, sponsored by Bracco Group. Primary endpoint: Complete resolution of tenesmus by day 5. Started Mar 2007; status: completed.
02
Drugs
Salcrozinenifedipine
03
Conditions
autoimmune colitisulcerative proctitisUlcerative rectosigmoiditis
Beyond the preview
Go deeper on 2006-003340-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003340-33.